- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05630924
Children's Lifestyle, Diet, and Exercise Intervention - CHILDREN's Project
October 23, 2023 updated by: Valentin Fuster, Icahn School of Medicine at Mount Sinai
Cluster randomized trial to evaluate the impact of a health promotion intervention (the SI! - Program NYC) on the adapted Ideal Cardiovascular Health score (aICH) in children enrolled in New York City elementary schools.
Study Overview
Status
Enrolling by invitation
Conditions
Intervention / Treatment
Detailed Description
Cluster randomized trial to evaluate the impact of a health promotion intervention (the SI! - Program NYC) on the adapted Ideal Cardiovascular Health score (aICH) in children enrolled in New York City elementary schools.
This study will enroll children of ages 5 to 6 and teachers from participating schools.
Participating schools will be randomized to an intervention group or a control (non-intervention group).
The SI! Program intervention will incorporate a comprehensive vision of cardiovascular health promotion that encompasses four basic components: body and heart, physical activity, healthy diet, and emotional management.
The intervention will take place at baseline and a reintervention will take place at 2 years-follow up.
The research team will assess an adapted version of the Ideal Cardiovascular Health (aICH) score (that includes body-mass-index Z-score, physical activity, diet, sleep time and smoking exposure) and the Knowledge, Attitudes, and Habits (KAH) score.
The aICH will be evaluated at baseline, 2 years and 4 years follow-up; the KAH will be evaluated at baseline and after the first intervention, and prior and after the second intervention.
The research team will also study the influence of factors in parents (socioeconomic and health-related variables), teachers (stress, teaching motivation, and health status), and the environment (pollution, housing, and neighborhood conditions) through parent/caregiver questionnaires, teacher questionnaires, publicly available data, and pollution data sourced from NASA satellites.
Study Type
Interventional
Enrollment (Estimated)
1294
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Contact
- Name: Valentin Fuster
- Phone Number: 212-241-7911
- Email: valentin.fuster@mountsinai.org
Study Contact Backup
- Name: Alexa Schulman
- Phone Number: 347-978-6114
- Email: alexa.schulman@mountsinai.org
Study Locations
-
-
New York
-
New York, New York, United States, 10029
- Icahn School of Medicine at Mount Sinai
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
4 years and older (Child, Adult, Older Adult)
Accepts Healthy Volunteers
Yes
Description
Inclusion Criteria:
- NYC Elementary school Kindergarten Children
- Parents and teachers of participating children
Exclusion Criteria:
- Children who are Wards of the State
- Children or parents who cannot provide legally effective consent
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Prevention
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: SI! Program-NYC Children
Receives 4 month health promotion educational intervention.
|
SI! Program-NYC incorporates a comprehensive and integrated vision of CV health promotion that encompasses four (4) basic and interrelated components: body and heart, physical activity healthy diet; and emotional management.
|
No Intervention: NYC Elementary School Children
The control group will be participating school children not enrolled in the program
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Adapted Ideal Cardiovascular Health Score (ICH)
Time Frame: Baseline
|
The adapted ideal cardiovascular health score (ICH) includes 5 components: body-mass-index Z-score, physical activity, diet, sleep/screen time, and passive smoking status.
The score will be calculated for five factors on a 0 to 100 scale, according to pre-defined, age adjused cut-offs recommended by the American Heart Association.
Higher values represent better health outcomes.
|
Baseline
|
Adapted Ideal Cardiovascular Health Score (ICH)
Time Frame: 2 years
|
The adapted ideal cardiovascular health score (ICH) includes 5 components: body-mass-index Z-score, physical activity, diet, sleep/screen time, and passive smoking status.
The score will be calculated for five factors on a 0 to 100 scale, according to pre-defined, age adjused cut-offs recommended by the American Heart Association.
Higher values represent better health outcomes.
|
2 years
|
Adapted Ideal Cardiovascular Health Score (ICH)
Time Frame: 4 years
|
The adapted ideal cardiovascular health score (ICH) includes 5 components: body-mass-index Z-score, physical activity, diet, sleep/screen time, and passive smoking status.
The score will be calculated for five factors on a 0 to 100 scale, according to pre-defined, age adjused cut-offs recommended by the American Heart Association.
Higher values represent better health outcomes.
|
4 years
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Knowledge, Attitudes, and Habits Score
Time Frame: 4 months
|
Questionnaires will be given to assess the knowledge (K), attitudes (A) and habits (H) of the children representing each of the components of the intervention (KAH-diet, KAH-physical activity, and KAH-human body).
An overall score representing the intervention as a whole (overall KAH) will be derived from the 39 items, ranging from 0-80.
The overall KAH score is derived from the sum of each component-specific score (Diet, 0 to 30 points; Physical activity, 0 to 30 points; and Human body, 0 to 20 points).
Higher scores indicate better health outcomes.
|
4 months
|
Knowledge, Attitudes, and Habits Score
Time Frame: Baseline
|
Questionnaires will be given to assess the knowledge (K), attitudes (A) and habits (H) of the children representing each of the components of the intervention (KAH-diet, KAH-physical activity, and KAH-human body).
An overall score representing the intervention as a whole (overall KAH) will be derived from the 39 items, ranging from 0-80.
The overall KAH score is derived from the sum of each component-specific score (Diet, 0 to 30 points; Physical activity, 0 to 30 points; and Human body, 0 to 20 points).
|
Baseline
|
Knowledge, Attitudes, and Habits Score
Time Frame: 2 years
|
Questionnaires will be given to assess the knowledge (K), attitudes (A) and habits (H) of the children representing each of the components of the intervention (KAH-diet, KAH-physical activity, and KAH-human body).
An overall score representing the intervention as a whole (overall KAH) will be derived from the 39 items, ranging from 0-80.
The overall KAH score is derived from the sum of each component-specific score (Diet, 0 to 30 points; Physical activity, 0 to 30 points; and Human body, 0 to 20 points).
Higher scores indicate better health outcomes.
|
2 years
|
Knowledge, Attitudes, and Habits Score
Time Frame: 2 years and 4 months
|
Questionnaires will be given to assess the knowledge (K), attitudes (A) and habits (H) of the children representing each of the components of the intervention (KAH-diet, KAH-physical activity, and KAH-human body).
An overall score representing the intervention as a whole (overall KAH) will be derived from the 39 items, ranging from 0-80.
The overall KAH score is derived from the sum of each component-specific score (Diet, 0 to 30 points; Physical activity, 0 to 30 points; and Human body, 0 to 20 points).
Higher scores indicate better health outcomes.
|
2 years and 4 months
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Collaborators
Investigators
- Principal Investigator: Valentin Fuster, Icahn School of Medicine at Mount Sinai
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
February 15, 2023
Primary Completion (Estimated)
July 1, 2029
Study Completion (Estimated)
July 1, 2029
Study Registration Dates
First Submitted
November 18, 2022
First Submitted That Met QC Criteria
November 18, 2022
First Posted (Actual)
November 30, 2022
Study Record Updates
Last Update Posted (Actual)
October 24, 2023
Last Update Submitted That Met QC Criteria
October 23, 2023
Last Verified
October 1, 2023
More Information
Terms related to this study
Other Study ID Numbers
- GCO 20-0655
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
YES
IPD Plan Description
Deidentified data will be available to external researchers upon request after approval with a signed data sharing agreement
IPD Sharing Time Frame
Starting 9 months after publication
IPD Sharing Access Criteria
Research team will respond with any requests to share IPD.
IPD Sharing Supporting Information Type
- SAP
- ICF
- CSR
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
product manufactured in and exported from the U.S.
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Healthy Lifestyle
-
Eindhoven University of TechnologyCompletedLifestyle | Lifestyle, Healthy | Lifestyle Risk Reduction | Lifestyle, SedentaryBelgium
-
Buchinger Wilhelmi Development & Holding GmbHKing's College London; Buchinger Wilhelmi Clinic; MVZ Labor Ravensburg GbR; Synlab...RecruitingHealthy Lifestyle | Healthy NutritionGermany
-
Igdir UniversityAtaturk UniversityRecruiting
-
Umeå UniversityRegion VästerbottenNot yet recruiting
-
Örebro University, SwedenRecruiting
-
Cedars-Sinai Medical CenterActive, not recruiting
-
Royal College of Surgeons, IrelandPrivate Philanthropic FunderCompleted
-
University Rovira i VirgiliErasmus Medical Center; Harokopio University; University of Exeter; Institut Investigacio... and other collaboratorsCompletedHealthy LifestyleSpain, Greece, Netherlands, United Kingdom
-
Dynamical Business and Science Society - DBSS International...CES University; INDEPORTES AntioquiaCompleted
-
Pontificia Universidad Catolica de ChileUniversity of Chile; Instituto de Nutrición y Tecnología de los Alimentos; Lallemand... and other collaboratorsCompleted
Clinical Trials on SI! Program-NYC
-
Chang Gung Memorial HospitalCompletedChild Development | Developmental Delay | Early Intervention
-
Fundación Centro Nacional de Investigaciones Cardiovasculares...CompletedCardiovascular Disease | Healthy LifestyleSpain
-
New York City Department of Health and Mental HygienePublic Health Solutions; The New York Academy of Medicine; New York City Health... and other collaboratorsActive, not recruiting
-
Istituto Nazionale di Ricovero e Cura per AnzianiMinistero dell'Università e della Ricerca, ItaliaRecruiting
-
Foundation for Science, Health and Education, SpainHospital del Mar Research Institute (IMIM); La Caixa FoundationEnrolling by invitationHealth Behavior | Healthy Lifestyle | Heart Disease Risk FactorsSpain
-
Fougera Pharmaceuticals Inc.Withdrawn
-
Sichuan Baili Pharmaceutical Co., Ltd.RecruitingNon-small Cell Lung CancerChina
-
Hyub HuhCompleted
-
Virginia Commonwealth UniversityCompletedMotor Coordination or Function; Developmental DisorderUnited States
-
Sichuan Baili Pharmaceutical Co., Ltd.RecruitingSquamous Cell Carcinoma of Head and NeckChina